Literature DB >> 10496266

Nutritional status is a prognostic factor for survival in ALS patients.

J C Desport1, P M Preux, T C Truong, J M Vallat, D Sautereau, P Couratier.   

Abstract

OBJECTIVE: To evaluate the occurrence of malnutrition in patients with ALS, to assess the relation of malnutrition to the neurologic deficit, and to determine the impact of nutritional status on patient survival.
BACKGROUND: Although ALS may be associated with significant malnutrition, the relative impact on patient survival has not yet been well established.
METHODS: In a prospective 7-month study of 55 ALS patients in a referral neurology practice, nutritional status was assessed by calculating body mass index. Neurologic evaluation includes four functional scores and identifies the form of disease onset. Slow vital capacity (VC) was also measured.
RESULTS: Occurrence of malnutrition in patients studied was 16.4%. Survival (using the Kaplan-Meier method) was worse for malnourished patients (p < 0.0001), with a 7.7-fold increased risk of death. Using multivariate analysis, only reduced VC (p < 0.0001) and malnutrition (p < 0.01) were found to have significant independent prognostic value. The degree of malnutrition is independent of neurologic scores and of forms of ALS onset.
CONCLUSION: Nutritional surveillance of ALS patients is very important, both in bulbar-onset and spinal-onset patients.

Entities:  

Mesh:

Year:  1999        PMID: 10496266     DOI: 10.1212/wnl.53.5.1059

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  91 in total

1.  [Cryptorchism].

Authors:  S I Volozhin
Journal:  Feldsher Akush       Date:  1975-10

Review 2.  The management of motor neurone disease.

Authors:  P N Leigh; S Abrahams; A Al-Chalabi; M-A Ampong; L H Goldstein; J Johnson; R Lyall; J Moxham; N Mustfa; A Rio; C Shaw; E Willey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

3.  Motor neurone disease: a practical update on diagnosis and management.

Authors:  Clare Wood-Allum; Pamela J Shaw
Journal:  Clin Med (Lond)       Date:  2010-06       Impact factor: 2.659

Review 4.  [Amyotrophic lateral sclerosis. Multisystem degeneration].

Authors:  A Hübers; A C Ludolph; A Rosenbohm; E H Pinkhardt; J H Weishaupt; J Dorst
Journal:  Nervenarzt       Date:  2016-02       Impact factor: 1.214

5.  Energy intake and amyotrophic lateral sclerosis.

Authors:  Mark P Mattson; Roy G Cutler; Simonetta Camandola
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

6.  Management of symptoms in amyotrophic lateral sclerosis.

Authors:  Lisa S Thibodeaux; Amparo Gutierrez
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

7.  Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial.

Authors:  Anne-Marie Wills; Jane Hubbard; Eric A Macklin; Jonathan Glass; Rup Tandan; Ericka P Simpson; Benjamin Brooks; Deborah Gelinas; Hiroshi Mitsumoto; Tahseen Mozaffar; Gregory P Hanes; Shafeeq S Ladha; Terry Heiman-Patterson; Jonathan Katz; Jau-Shin Lou; Katy Mahoney; Daniela Grasso; Robert Lawson; Hong Yu; Merit Cudkowicz
Journal:  Lancet       Date:  2014-02-28       Impact factor: 79.321

8.  Therapeutic decisions in ALS patients: cross-cultural differences and clinical implications.

Authors:  Peter M Andersen; Magdalena Kuzma-Kozakiewicz; Jürgen Keller; Helena E A Aho-Oezhan; Katarzyna Ciecwierska; Natalia Szejko; Cynthia Vázquez; Sarah Böhm; Gisela Badura-Lotter; Thomas Meyer; Susanne Petri; Katharina Linse; Andreas Hermann; Olof Semb; Erica Stenberg; Simona Nackberg; Johannes Dorst; Ingo Uttner; Ann-Cristin Häggström; Albert C Ludolph; Dorothée Lulé
Journal:  J Neurol       Date:  2018-05-04       Impact factor: 4.849

9.  Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis.

Authors:  Edward J Kasarskis; Marta S Mendiondo; Dwight E Matthews; Hiroshi Mitsumoto; Rup Tandan; Zachary Simmons; Mark B Bromberg; Richard J Kryscio
Journal:  Am J Clin Nutr       Date:  2014-02-12       Impact factor: 7.045

10.  Serum irisin is upregulated in patients affected by amyotrophic lateral sclerosis and correlates with functional and metabolic status.

Authors:  Christian Lunetta; Andrea Lizio; Lucio Tremolizzo; Massimiliano Ruscica; Chiara Macchi; Nilo Riva; Patrick Weydt; Ettore Corradi; Paolo Magni; Valeria Sansone
Journal:  J Neurol       Date:  2018-10-22       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.